"4PL Central Station is the leader in Europe and we have almost no competitors in our field of fourth party logistics."
In Conversation
"We expect that the significant investment and big engagements we have made in recent years in bringing new technologies to the Serbian health sector will start…
"The local requirements for national registration of a drug in Serbia, since Serbia is not part of the EU thus the centralized registration does not apply,…
"At DHL Express what we bank on is speed, which is central to the life sciences industry whether it is in relation to research and development…
"In the pharmaceutical industry, market access has become a crucial area for several decades already, and the continuous development and refinement of these capacities are truly…
"We are indeed expecting tremendous growth in the animal health market; industry experts expect a growth rate of five to eight percent per year."
"In Serbia, in certain cases, if you have a locally registered legal entity, you have to have an insurance policy issued by a local insurance company."
"One of our strategic plan for the coming years is to level a large part of our product portfolio with EU standards and fill in the…
"We have built our position here step by step, going from being Mr. Nobody in Poland to having a strong presence in gastroenterology, oncology and now,…
"Since 2014, we have already united 69 member companies which shows that there is clear interest in building relationships in this community and seeking out other…
"The strategy of Mylan in the Baltic region is aligned to the global one, which lies in increasing access to high quality medicines worldwide through introducing…
"The Serbian market is a generic-dominated market, with the local manufacturers still enjoying a privileged status."
